Gilteritinib with standard chemotherapy for newly diagnosed FLT3-mutation-positive acute myeloid leukaemia when intensive chemotherapy is suitable [TSID12331]

  • Awaiting development
  • GID-TA11936
  • Expected publication date: TBC

27575-Gilteritinib-Chemotherapy-for-Acute-Myeloid-Leukaemia-V1.0-NOV2025-NON-CONF.pdf